Introduction
Sjogren syndrome is caused by a misdirected immune response in which the body attacks the glands that produce tears and saliva, and in some people it also affects other tissues. The condition does not arise from a single trigger. Instead, it develops through a combination of immune dysregulation, genetic susceptibility, hormonal influences, environmental exposures, and in some cases other autoimmune diseases or infections that help initiate or amplify the process.
At its core, Sjogren syndrome reflects a breakdown in immune tolerance, the body’s ability to distinguish its own tissues from harmful foreign material. Once that control fails, immune cells accumulate in the glands, inflammatory signals rise, and normal fluid-producing tissue becomes damaged. Understanding the condition therefore means understanding how the immune system becomes activated, why it targets exocrine glands, and why the process persists.
Biological Mechanisms Behind the Condition
The glands most often affected in Sjogren syndrome are the lacrimal glands, which produce tears, and the salivary glands, which produce saliva. Under normal conditions, these glands are protected by a balanced immune environment and supported by specialized epithelial cells that help regulate secretion. In Sjogren syndrome, that balance is disrupted. Immune cells, especially T cells and B cells, infiltrate glandular tissue and drive chronic inflammation.
This inflammation is not simply a passive reaction to damage. The glandular epithelial cells themselves appear to participate in the immune response by expressing molecules that attract and activate immune cells. They may present antigens, release inflammatory signals, and perpetuate immune activation. Over time, the gland becomes a site of ongoing immune stimulation rather than a simple fluid-producing organ.
Several immune pathways are involved. T helper cells promote inflammation by releasing cytokines that recruit and activate other immune cells. B cells become overactive and can produce autoantibodies, including antibodies against SSA/Ro and SSB/La in many patients. These antibodies are markers of the disease and are thought to reflect broader immune activation. Cytokines such as interferons, tumor necrosis factor, and interleukins help maintain the inflammatory environment.
As inflammation continues, gland tissue can be gradually replaced by immune infiltrates and fibrotic change. The secretory cells become less effective, ducts may be altered, and the normal architecture of the gland is disrupted. The result is reduced tear and saliva output. Importantly, the dry mouth and dry eyes are consequences of a deeper immune-mediated process rather than isolated gland failure.
Primary Causes of Sjogren syndrome
Sjogren syndrome is generally considered an autoimmune disease with no single definitive cause. The most important contributors are immune system dysfunction, genetic susceptibility, and hormonal influences, often acting together. In many patients, the disease develops without one obvious initiating event, but these factors increase the probability that the immune system will become self-reactive.
Autoimmune immune dysregulation is the central cause. The immune system normally recognizes self-tissues and avoids attacking them through central and peripheral tolerance mechanisms. In Sjogren syndrome, those tolerance mechanisms fail. Autoreactive T and B cells survive, become activated, and target glandular tissue. This creates chronic inflammation and gland dysfunction. The disease is considered primary when it occurs on its own, rather than as part of another autoimmune disorder.
Genetic predisposition is another major cause. Certain inherited immune response patterns make a person more vulnerable to developing Sjogren syndrome. These genetic influences do not guarantee disease, but they shape immune behavior in ways that can favor autoimmunity. Variants in genes related to antigen presentation, interferon signaling, and immune regulation have been associated with increased risk. Such variants may make the immune system more likely to respond strongly to self-antigens or less able to shut down inappropriate immune activation.
Hormonal influences also play an important role, especially because Sjogren syndrome is far more common in women. Estrogen and other sex-related hormones affect immune function, B cell activity, and inflammatory signaling. Female hormonal patterns may help explain why the disease often appears during middle adulthood and why women are disproportionately affected. The exact mechanism is not fully defined, but the sex bias strongly suggests that hormonal regulation contributes to disease susceptibility.
Chronic activation of B cells is part of the causal process, not just a consequence. In many patients, B cells behave as though the body is persistently encountering an antigen. They produce autoantibodies, present antigens to T cells, and release inflammatory mediators. This overactivity helps sustain the autoimmune cycle. In some individuals, the immune response becomes so dysregulated that glandular tissue is continuously exposed to inflammatory injury.
Contributing Risk Factors
Several factors can increase the likelihood of Sjogren syndrome developing, even if they do not directly cause it on their own. These factors influence the immune system’s threshold for activation or alter the local tissue environment in ways that make autoimmunity more likely.
Genetic influences include family history and inherited immune traits. Having a close relative with an autoimmune disease does not mean a person will develop Sjogren syndrome, but it suggests a shared vulnerability in immune regulation. Many autoimmune diseases cluster in families, indicating that broad immune susceptibility can be inherited even if the exact disease varies.
Environmental exposures may contribute by stimulating the immune system or damaging tissues in a way that exposes self-antigens. Certain chemicals, dusts, or other environmental stresses have been investigated as possible contributors, although no single exposure has been proven to cause the disease in all cases. Environmental factors may matter most when they repeatedly challenge the immune system in a genetically susceptible person.
Infections are frequently discussed as potential triggers. Viral infections may activate immune pathways that accidentally target host tissues through molecular mimicry or bystander activation. In molecular mimicry, parts of a virus resemble components of human tissue, leading the immune system to attack both. In bystander activation, infection-driven inflammation creates an environment in which autoreactive immune cells are more likely to expand. Several viruses have been studied in relation to Sjogren syndrome, but no single infectious agent has been established as the universal cause.
Hormonal changes such as those occurring around menopause may increase susceptibility. Reduced estrogen levels may alter immune regulation and the function of exocrine glands. This may help explain why symptoms frequently emerge in midlife, when hormonal patterns change and immune balance may shift.
Lifestyle factors are less clearly causal, but chronic stress, smoking, and poor general health may influence immune function and inflammatory tone. Smoking, for example, can affect mucosal surfaces and immune signaling, potentially worsening tissue vulnerability. Stress may change neuroendocrine regulation of immunity, although it is not considered a primary cause.
How Multiple Factors May Interact
Sjogren syndrome usually develops through interaction among several biological systems rather than through a single pathway. A person may inherit a tendency toward heightened immune reactivity, then encounter an environmental or infectious trigger that activates immune cells. If hormonal factors are also present, the immune response may become even more prone to persistence. Once glandular inflammation begins, the local tissue environment changes in ways that reinforce the autoimmune process.
This interaction creates a self-sustaining cycle. Initial immune activation brings lymphocytes into the glands. Those immune cells release cytokines that attract more immune activity. The epithelial cells of the gland respond by expressing additional inflammatory signals. Tissue injury then exposes more antigens, which can further stimulate autoreactive lymphocytes. In this way, immune, epithelial, and inflammatory pathways amplify one another.
The disease is therefore best understood as a network failure. Genes influence the baseline immune set point, environmental exposures may initiate or intensify the response, hormones alter susceptibility, and the glands themselves become part of the inflammatory process. No single factor is sufficient in many patients, but the combination can be enough to shift the system into chronic autoimmunity.
Variations in Causes Between Individuals
The causes of Sjogren syndrome vary widely from one person to another because the disease reflects different combinations of susceptibility and trigger. Some patients have a strong family history of autoimmunity and likely develop the condition because of inherited immune patterns. Others may have no clear family history but experience an infectious or environmental event that appears to precede symptoms. In many cases, the initiating factor is never identified.
Age can influence both risk and disease expression. The condition is most often diagnosed in middle age, but the biological basis may have been developing for years before diagnosis. Older adults may accumulate immune changes over time, while younger patients may have stronger genetic predisposition or overlap with other autoimmune diseases. The timing of onset often reflects when the balance between immune control and immune activation is lost.
Overall health status also matters. People with existing autoimmune activity, chronic inflammation, or altered endocrine function may have a lower threshold for developing Sjogren syndrome. Their immune systems may already be primed toward self-reactivity, making glandular tissue more vulnerable to attack. Differences in general immune resilience can therefore shape how and when the disease appears.
Environmental exposure patterns differ as well. One person may have repeated viral exposures, another may encounter occupational irritants, and another may have minimal identifiable environmental stress. Because the disease requires a convergence of factors, the specific contributors can vary substantially even when the underlying pathology is similar.
Conditions or Disorders That Can Lead to Sjogren syndrome
Sjogren syndrome may occur as a primary condition or as a secondary autoimmune disorder, meaning it develops alongside another immune-mediated disease. In secondary cases, the same general autoimmune tendency affects multiple tissues, and the presence of one disease may indicate a system already prone to immune misdirection.
Rheumatoid arthritis is one of the most common disorders associated with Sjogren syndrome. Both conditions involve immune dysregulation and chronic inflammation. In patients with rheumatoid arthritis, the immune system is already attacking joint tissues, and overlapping autoimmune pathways may also target exocrine glands.
Systemic lupus erythematosus is another important associated disorder. Lupus involves widespread immune complex formation, autoantibody production, and tissue inflammation. Because the immune abnormalities are broad, glandular involvement can emerge as part of the same underlying process.
Scleroderma, polymyositis, and autoimmune thyroid disease may also coexist with Sjogren syndrome. These diseases share a tendency toward loss of immune tolerance. In a person with one autoimmune disorder, the immune system may be more likely to generate additional autoantibodies and target new tissues, including salivary and lacrimal glands.
In some cases, Sjogren syndrome may be associated with chronic viral infections or persistent immune stimulation from another source. While this does not mean infection directly causes the disease in every case, long-term immune activation can increase the chance that autoreactive immune cells will persist and expand. The relationship is usually indirect, involving immune activation rather than simple infection of the glands.
Conclusion
Sjogren syndrome develops because the immune system loses tolerance to the body’s own glandular tissues, especially the salivary and tear glands. The disease is driven by chronic immune infiltration, B cell and T cell activation, inflammatory cytokine signaling, and progressive disruption of gland structure and function. Its causes are multifactorial, with genetic susceptibility, hormonal influences, environmental exposures, infections, and coexisting autoimmune disorders all contributing to the risk.
What makes Sjogren syndrome distinctive is not just gland dryness, but the immune process that produces it. The condition emerges when several biological systems intersect: inherited immune traits create vulnerability, triggers stimulate immune activity, and glandular tissue becomes a target of persistent inflammation. Understanding these mechanisms explains why Sjogren syndrome occurs, why it varies from person to person, and why it is best viewed as a complex autoimmune disorder rather than a simple gland problem.